BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 5881044)

  • 1. Studies on autoprothrombin C thrombin relationship.
    Landaburu RH; Abdala O; Fulginiti S; Curtino J
    Thromb Diath Haemorrh; 1965 Sep; 14(1):176-83. PubMed ID: 5881044
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on autoprothrombin C thrombin relationship.
    Landaburu RH; Abdala O; Fulginiti S; Curtino J
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):176-83. PubMed ID: 16955974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect on blood coagulation of the trypsin-like protease from Astacus leptodactylus (Crustacea)].
    Zwilling R; Moizeszowicz-Podzun I; Breddin K
    Thromb Diath Haemorrh; 1970 May; 23(2):360-8. PubMed ID: 5426215
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
    Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
    Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activation by heparin-Sepharose of prothrombin conversion to prethrombin 1].
    Strukova SM; Mitroshina TN; Kudriashov BA
    Biokhimiia; 1981 May; 46(5):904-10. PubMed ID: 7295815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the primary structure of bovine thrombin.
    Magnusson S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):385-90. PubMed ID: 4121331
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the esterase (TAMe) and clotting activities of human and bovine thrombin preparations.
    Lanchantin GF; Presant CA; Hart DW; Friedmann JA
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):159-75. PubMed ID: 16955973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
    Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
    Brister SJ; Ofosu FA; Buchanan MR
    Thromb Haemost; 1993 Aug; 70(2):259-62. PubMed ID: 8236131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of blood clotting factors.
    MARCINIAK E; RODRIGUEZ-ERDMANN F; SEEGERS WH
    Science; 1962 Aug; 137(3528):421-2. PubMed ID: 14469665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
    Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
    Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K; Lind H; Blombäck M
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on hyaline membranes.
    ARONSON N
    Pediatrics; 1961 Apr; 27():567-77. PubMed ID: 13684465
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
    Chan AK; Berry LR; Monagle PT; Andrew M
    Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SEPARATION OF AUTOPROTHROMBIN III FROM BOVINE PROTHROMBIN PREPARATIONS.
    SEEGERS WH; COLE ER; AOKI N; HARMISON CR
    Can J Biochem; 1964 Feb; 42():229-33. PubMed ID: 14126733
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.